BioRegenx, Inc. (BRGX)
OTCMKTS · Delayed Price · Currency is USD
0.0030
-0.0015 (-33.33%)
At close: Oct 12, 2026

BioRegenx Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
3129---
Market Cap Growth
-80.44%44.15%----
Enterprise Value
51511---
Last Close Price
0.000.010.01---

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
1.656.693.68---
PB Ratio
--2.73-2.55---
P/FCF Ratio
154.64414.83----
P/OCF Ratio
104.45318.43----

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
2.857.884.57---
EV/FCF Ratio
267.09488.63----

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
-0.48-0.49-0.64-0.72-1.20-1.07
Debt / FCF Ratio
114.8874.03----
Net Debt / Equity Ratio
-0.47-0.47-0.62-0.66-1.19-0.80
Net Debt / EBITDA Ratio
-7.05-4.83-0.49-0.40-3.27-0.81
Net Debt / FCF Ratio
112.4571.71-4.10-0.90-3.72-0.66
Asset Turnover
4.314.033.417.380.042.10
Inventory Turnover
2.743.224.15--1.90
Quick Ratio
0.020.030.020.080.010.30
Current Ratio
0.050.060.090.230.010.63
Return on Assets (ROA)
-57.36%-70.55%-595.83%-460.70%-4.95%-106.97%
Return on Capital Employed (ROCE)
10.30%14.20%209.60%177.40%1366.40%303.70%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-44.71%-12.44%-267.80%---
FCF Yield
0.65%0.24%-5.96%---
Buyback Yield / Dilution
-0.32%-5.19%-42.61%-137.18%-664.87%-1.01%